Servier, founded in 1954, is the first French independent pharmaceutical group. We are present in 140 countries, with more than 21 000 employees, including close to 3000 in R&D.
Servier and Pfizer announce FDA clearance of IND application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia
Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance
New compound shows promise in treating multiple human cancers
> All News
© 2017 SERVIER HONG KONG LIMITED, an incorporated company of Servier. All Rights Reserved. Report a side-effect with a drug.